Cronos Appoints Anna Shlimak as Chief Financial Officer

Core Viewpoint - Cronos Group Inc. has appointed Anna Shlimak as Chief Financial Officer, succeeding James Holm, who will assist in the transition until April 18, 2025 [1][4] Group 1: Leadership Transition - Anna Shlimak has been part of Cronos' leadership for seven years, significantly contributing to the company's strategy and operational efficiencies [2] - Mike Gorenstein, President and CEO, expressed confidence in Shlimak's ability to drive financial strategy and growth, highlighting her understanding of the business and track record [3] - James Holm acknowledged the accomplishments during his tenure and expressed confidence in Shlimak's leadership for future growth [4] Group 2: Anna Shlimak's Background - Prior to her CFO role, Shlimak was the Chief Strategy Officer, overseeing corporate strategy, investor relations, and communications [5] - Shlimak has experience in investor relations at Quest Partners LLC and various roles at the New York Stock Exchange [5] - She holds an MBA from Columbia Business School and a Bachelor of Science in Economics from The Wharton School [5] Group 3: Company Overview - Cronos Group is a global cannabinoid company focused on cannabis research, technology, and product development [6] - The company aims to build a diverse brand portfolio, including Spinach®, PEACE NATURALS®, and Lord Jones® [6]